(E)-2-甲基-5-辛烯-2-醇 | 55928-73-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: (E)-2-甲基-5-辛烯-2-醇
• 英文名称: 2-Methyl-trans-5-octen-2-ol
• 英文别名: 2-methyl-oct-5t-en-2-ol；(E)-2-Methyloct-5-en-2-ol
• CAS: 55928-73-9
• 化学式: C₉H₁₈O
• 分子量: 142.241
• InChiKey: LGAOBFAFWKTUEZ-AATRIKPKSA-N

物化性质

• 沸点：
  204.2±9.0 °C(Predicted)
• 密度：
  0.845±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  10
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.78
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  2-methyl-6-tetrahydropyran-2-yloxy-oct-4-yn-2-ol 生成 (E)-2-甲基-5-辛烯-2-醇
  参考文献：
  名称：

  Claesson,A., Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry, 1974, vol. 28, p. 993 - 997

  摘要：

  DOI：

文献信息

• FLUORINATED MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS
  申请人：Gai Yonghua

  公开号：US20090238794A1

  公开（公告）日：2009-09-24

  The present invention discloses compounds of formula I or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
• US8372802B2
  申请人：——

  公开号：US8372802B2

  公开（公告）日：2013-02-12
• Claesson,A., Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry, 1974, vol. 28, p. 993 - 997
  作者：Claesson,A.

  DOI：——

  日期：——